Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Rheumatology

• Publication date

  1992-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 1363476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.

  1991cited by this paper
• Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.

  1991cited by this paper
• Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.

  1991cited by this paper
• Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody.

  1991cited by this paper
• Rheumatoid arthritis complicated by infection with the human immunodeficiency virus (HIV)

  1990cited by this paper
• Expression of Activation Antigens on T Cells in Rheumatoid Arthritis Patients

  1990cited by this paper
• Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome.

  1989cited by this paper
• Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.

  1989cited by this paper
• Immunosuppression with monoclonal antibodies in multiple sclerosis

  1988cited by this paper
• Functional and Phenotypical Characterization of Activated T Cells from Intra‐articular Sites in Inflammatory Joint Diseases

  1987cited by this paper
• Monoclonal anti-CD4 in arthritis.

  1987cited by this paper
• Production of hybridoma growth factor by human monocytes

  1987cited by this paper
• The isolation and characterization of the human suppressor inducer T cell subset.

  1985cited by this paper
• Lymphapheresis in rheumatoid arthritis. A randomized trial.

  1981cited by this paper
• Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis.

  1981cited by this paper
• Treatment of intractable rheumatoid arthritis with total lymphoid irradiation.

  1981cited by this paper
• Immunological and Functional Characteristics of Peripheral Blood and Synovial Fluid Lymphocytes from Patients with Rheumatoid Arthritis

  1978cited by this paper
• Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage.

  1977cited by this paper

• The Epitope-Specific Anti-human CD4 Antibody MAX.16H5 and Its Role in Immune Tolerance

  2019influential citation
• Adaptationen von T Helferlymphozyten an chronische Entzündungen

  2018cites this paper
• Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo

  2017cites this paper
• [Biologics].

  2016cites this paper
• Leitthema: Meilensteine in der Rheumatologie: 75 Bände Innovation

  2016cites this paper
• [Pathogenic cells of rheumatic inflammation as the target of modern therapies].

  2015cites this paper
• Pathogene Zellen der rheumatischen Entzündung als Ziele moderner Therapien

  2015cites this paper
• 1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade.

  2013cites this paper
• Immunopharmacology Reviews Volume 2

  2011cites this paper
• Targeting pathogenic T helper cell memory

  2011cites this paper
• Induction of Immunological Tolerance/Hyporesponsiveness in Baboons with a Nondepleting CD4 Antibody

  2004cites this paper
• This information is current as with a Nondepleting CD 4 Antibody Tolerance / Hyporesponsiveness in Baboons Induction of Immunological

  2004cites this paper
• Donor‐specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft

  2003cites this paper
• Pancreatic Islet Cell Transplantation

  2003cites this paper
• Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft

  2003cites this paper
• Studies of pharmacological interventions and pathogenesis of rheumatoid arthritis

  2002cites this paper
• Human islet cell transplantation – future prospects

  2001cites this paper
• Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.

  2001cites this paper
• Anti-CD4 monoclonal antibody therapy in human autoimmune diseases.

  2000cites this paper
• The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.

  2000cites this paper
• Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates.

  1999cites this paper
• Permanent survival of organ transplants without immunosuppression: Experimental approaches and possibilities for tolerance induction in clinical transplantation

  1999cites this paper
• Induction of unresponsiveness to islet xenografts by a short-course treatment by anti-CD4 nondepleting monoclonal antibody.

  1998cites this paper
• Biological Agents in Rheumatoid Arthritis

  1998cites this paper
• Biological agents in rheumatoid arthritis: which ones could be used in combination?

  1998cites this paper
• A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.

  1998cites this paper
• Clinical trials on biologics in rheumatoid arthritis.

  1998cites this paper
• Long‐term survival of hamster islet xenografts in mice under short‐course treatment with nondepleting versus depleting anti‐CD4 monoclonal antibodies

  1998cites this paper
• Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.

  1998cites this paper
• Depletion of CD8+ T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis C.

  1997cites this paper
• Differential functional effects of a humanized anti‐CD4 antibody on resting and activated human T cells

  1997cites this paper
• Persistence of CD4+ T cells in the arthritic joint after CAMPATH-1H treatment.

  1997cites this paper
• Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations.

  1997cites this paper
• Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.

  1997cites this paper
• Biologic Interventions in Autoimmune Diseases

  1996cites this paper
• Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.

  1996cites this paper
• Transplantation tolerance induced by antigen pretreatment and depleting anti‐CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response

  1995cites this paper
• The Experimental and Clinical Use in Transplantation of Monoclonal Antibodies to CD4 and Other Adhesion Molecules

  1995cites this paper
• Expansions of Vα12 CD8+ T‐Cells in Rheumatoid Arthritis a

  1995cites this paper
• Expansions of V alpha 12 CD8+ T-cells in rheumatoid arthritis.

  1995cites this paper
• Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugate.

  1995cites this paper
• [Immunomodulating therapy of rheumatoid arthritis (chronic polyarthritis): use of monoclonal antibodies].

  1995cites this paper
• New therapeutic approaches in autoimmune rheumatic diseases, with special emphasis on rheumatoid arthritis.

  1995cites this paper
• [Perspectives of application of anti-CD4 antibodies in the treatment of autoimmune diseases].

  1994cites this paper
• Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children.

  1994cites this paper
• Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts.

  1994cites this paper
• T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.

  1994cites this paper
• Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade.

  1994cites this paper
• Monoclonal antibody therapy in rheumatic disease.

  1994cites this paper
• Monoclonal Antibodies in the Treatment of Rheumatoid Arthritis

  1994cites this paper
• Rheumatoid pericarditis: new immunopathological aspects.

  1994cites this paper
• Are there special considerations relevant to trials of biologic agents?

  1994cites this paper
• Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. A protocol with significant clinical potential.

  1994cites this paper
• [Monoclonal antibodies and rheumatoid polyarthritis].

  1993cites this paper
• Immunotherapy of autoimmune disease.

  1993cites this paper
• Anticorps monoclonaux et polyarthrite rhumatoïde

  1993cites this paper
• Reduction of monocyte‐macrophage activation markers upon anti‐CD4 treatment. Decreased levels of IL‐1, IL‐6, neopterin and soluble CD14 in patients with rheumatoid arthritis

  1993cites this paper